(Q38268512)

1 September 2017

1 reference

title

Treatment of drug-resistant Shigella infections (English)

1 reference

1 September 2017

Karl C Klontz

1

1 reference

1 September 2017

Nalini Singh

series ordinal

2

1 reference

1 September 2017

publication date

17 November 2014

1 reference

Expert Review of Anti-infective Therapy

1 September 2017

published in

1 reference

1 September 2017

volume

13

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

69-80

1 reference

A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Molecular epidemiology of Shigella flexneri in a diarrhoea-endemic area of Lima, Peru.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial resistance in organisms causing diarrheal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Global causes of diarrheal disease mortality in children <5 years of age: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Treatment of acute diarrhea in outpatients. Double-blind study comparing ampicillin and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Acute infectious diarrhea in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Sensitivity studies on Shigella sonnei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Chloramphenicol and terramycin in the treatment of Salmonella and Shigella infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

In-vitro susceptibility of E. coli, Shigellae and Salmonellae to kanamycin and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

TRANSFERABLE ANTIBIOTIC RESISTANCE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Infectious Drug Resistance in Enteric Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

The problems of drug-resistant pathogenic bacteria. Epidemiology and genetics of R factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Further studies on the antibiotic resistance of Shigella sonnei. II. The acquisition of transferable antibiotic resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

R factors in strains of Shigella dysenteriae type 1 isolated in the western hemisphere during 1969-1970.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antibiotic resistance in Shigella mediated by R factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Shigellosis. To treat or not to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Randomized trial of high- and low-dose ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Further studies on the antibiotic resistance ofShigella sonnei: I. Transferable antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Ampicillin resistance of Shigella sonnei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Letter: Transfer of ampicillin resistance from Shigella dysenteriae type 1 to Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Resistance of Shigella dysenteriae type 1 to ampicillin and other antimicrobial agents: strains isolated during a dysentery outbreak in a hospital in Mexico City

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Beta-lactamase activity in Shigella sonnei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Letter: Ampicillin-resistant Shiga bacillus in Bangladesh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Sulfamethoxazole- trimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

The changing pattern of resistance to ampicillin and co-trimoxazole in Shigella serotypes in Bangalore, southern India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Co-trimoxazole-resistant Shigella dysenteriae type 1 outbreak in a family in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Acquisition of trimethoprim resistance in epidemic strain of Shigella dysenteriae type 1 from Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Clinical Evaluation of Co-trimoxazole and Furazolidone in Treatment of Shigellosis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Resistant Shigella dysenteriae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Which chemotherapy for shigella dysentery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Clinical and Bacteriological Evaluation of Antibiotic Treatment in Shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Comparative Efficacy of Cephalexin and Ampicillin for Shigellosis and Other Types of Acute Diarrhea in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Mecillinam: a new antibiotic for enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial Resistance of Shigella Isolates in Bangladesh, 1983-1990: Increasing Frequency of Strains Multiply Resistant to Ampicillin, Trimethoprim-Sulfamethoxazole, and Nalidixic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Long-term comparison of antibiotic resistance in Vibrio cholerae O1 and Shigella species between urban and rural Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Multiresistant Shigella infections in Bangladesh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

A large outbreak of antibiotic-resistant shigellosis at a mass gathering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Marked decrease in susceptibility of Shigella to ampicillin and cotrimoxazole in Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Short-term pefloxacin therapy in Madagascan children with shigellosis due to multiresistant organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Multidrug-resistant Shigella dysenteriae type 1: forerunners of a new epidemic strain in eastern India?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2000-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

HIV infection as a risk factor for shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Ciprofloxacin-resistant Shigella sonnei among men who have sex with men, Canada, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Quinolone resistance among Shigella spp. isolated from travellers returning from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Practice guidelines for the management of infectious diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Reduced azithromycin susceptibility in Shigella sonnei, United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Macrolide-resistant Shigella sonnei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

CTX-M-55-type extended-spectrum β-lactamase-producing Shigella sonnei isolated from a Korean patient who had travelled to China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Third-generation cephalosporin resistance in Shigella sonnei, Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

CTX-M-3 Extended-spectrum ß-lactamase in a Shigella sonnei Clinical Isolate: First Report from Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

SHV-type extended-spectrum beta-lactamase in a Shigella flexneri clinical isolate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Rapid emergence of third generation cephalosporin resistant Shigella spp. in Southern Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Emergence of multidrug-resistant salmonella concord infections in Europe and the United States in children adopted from Ethiopia, 2003-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

An update on vaccines against Shigella

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Risk factors for shigellosis in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Breast feeding as a determinant of severity in shigellosis. Evidence for protection throughout the first three years of life in Bangladeshi children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial-resistant epidemic Shigella dysenteriae type 1 in Zambia: modes of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Single-Dose Tetracycline Therapy for Shigellosis in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995-2010): a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

Decrease in resistance to ampicillin and co-trimoxazole in Shigella species isolated from faeces, 1983-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

In vitro activity of eight antibiotics against Salmonella and Shigella species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.983902

10.1586/14787210.2015.983902

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference